The screening of two libraries of compounds using three neuroendocrine tumor derived cell lines identified NAMPT and HDAC inhibitors as two classes of compounds particularly effective in reducing neuroendocrine tumor cell viability and proliferation. Here, HDAC9 is linked to neuroendocrine neoplasm.